Denali Therapeutics
DNLI
DNLI
266 hedge funds and large institutions have $2.82B invested in Denali Therapeutics in 2026 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 104 increasing their positions, 57 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
13% more capital invested
Capital invested by funds: $2.5B → $2.82B (+$325M)
7% more funds holding
Funds holding: 249 → 266 (+17)
10.11% less ownership
Funds ownership: 103.06% → 92.95% (-10%)
Holders
266
Holding in Top 10
5
Calls
$11.4M
Puts
$6.78M
Top Buyers
| 1 | +$36.2M | |
| 2 | +$26M | |
| 3 | +$25.2M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
+$24.5M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$21.9M |
Top Sellers
| 1 | -$33.8M | |
| 2 | -$30.3M | |
| 3 | -$28.9M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$24.2M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$16.9M |
